Beryl Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-250,000
Closed -$12.9M 38
2022
Q3
$12.9M Buy
+250,000
New +$10.3M 1.37% 14

Other funds holding CCXI

Beryl Capital Management's CCXI Position: Q4 2022 in Review

Beryl Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 250,000 shares — an estimated $12.9M sold.

Beryl Capital Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $12.9M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Beryl Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Beryl Capital Management sold 250,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $12.9M.
  • Beryl Capital Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Beryl Capital Management's ChemoCentryx, Inc. position peaked at $12.9M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Beryl Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.